416 related articles for article (PubMed ID: 30047430)
1. Systemic sclerosis: Current concepts of skin and systemic manifestations.
Pearson DR; Werth VP; Pappas-Taffer L
Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
[TBL] [Abstract][Full Text] [Related]
2. Frontiers in translational systemic sclerosis research: A focus on the unmet 'cutaneous' clinical needs (Viewpoint).
Herrick AL; Shukla R; Watson REB
Exp Dermatol; 2020 Dec; 29(12):1144-1153. PubMed ID: 32840924
[TBL] [Abstract][Full Text] [Related]
3. Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A
Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
[TBL] [Abstract][Full Text] [Related]
4. [Calcinosis, Raynaud's disease, slcerodactylia and telangiectasias in progressive systemic sclerosis. Statistic analysis of contingencies].
Mintz G
Gac Med Mex; 1974 Jun; 107(6):525-36. PubMed ID: 4448356
[No Abstract] [Full Text] [Related]
5. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
Volkmann ER; Furst DE
Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of acral manifestations of systemic sclerosis].
Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and digital ulcers: advances in evaluation and management.
Herrick AL
Curr Opin Rheumatol; 2021 Nov; 33(6):453-462. PubMed ID: 34420003
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon.
Devgire V; Hughes M
Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
[TBL] [Abstract][Full Text] [Related]
11. [Hand involvement in systemic sclerosis].
Mouthon L
Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
[TBL] [Abstract][Full Text] [Related]
12. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
Galluccio F; Matucci-Cerinic M
Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
[TBL] [Abstract][Full Text] [Related]
13. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
[TBL] [Abstract][Full Text] [Related]
14. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis: successful treatment of ulcerations, pain, Raynaud's phenomenon, calcinosis, and dysphagia by transcutaneous nerve stimulation. A case report.
Kaada B
Acupunct Electrother Res; 1984; 9(1):31-44. PubMed ID: 6145309
[TBL] [Abstract][Full Text] [Related]
16. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
17. Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.
Santiago T; Duarte AC; Sepriano A; Castro A; Rosa B; Resende C; Oliveira D; Dourado E; Costa E; Cunha-Santos F; Terroso G; Boleto G; Silva I; Barbosa L; Silva J; Sousa Neves J; Salvador MJ; Gonçalves MJ; Gomes Guerra M; Miriam Ferreira R; Duarte-Fernandes R; Barreira S; Silvestre Teixeira V; Tomás AL; Romão V; Cordeiro A
ARP Rheumatol; 2024; 3(2):84-94. PubMed ID: 38956991
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis - the dermatological perspective.
Sticherling M
J Dtsch Dermatol Ges; 2019 Jul; 17(7):716-728. PubMed ID: 31364293
[TBL] [Abstract][Full Text] [Related]
19. The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis.
Pauling JD
Expert Rev Clin Immunol; 2018 May; 14(5):431-442. PubMed ID: 29641934
[TBL] [Abstract][Full Text] [Related]
20. [Sclerodermic acrosyndromes].
Carpentier PH
Rev Prat; 2002 Nov; 52(17):1891-5. PubMed ID: 12532865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
